Newly Launched RegScale Announces $1.5M Early Funding Round and Key Customers for Its Security and Compliance Automation Software Platform
Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company have led a USD 156m Series B funding round for biotechnology business Quell Therapeutics.